Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Azacitidine monotherapy versus combination regimens as post-allogeneic transplantation maintenance in high-risk myeloid malignancies: A retrospective cohort Study

Ying Shen, Pengyu Zhang, Aili He, Jianli Wang, Jie Liu, Wanhong Zhao, Liufang Gu, Jin Wang, Bo Lei, Xueying Li, Yun Yang

Blood (2025) 146 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2025-2499

Published: 2025

Journal Articles

QLS4131, a next-generation GPRC5D×BCMA×CD3 trispecific T-cell engager, in patients with relapsed/refractory multiple myeloma (RRMM): Initial results of a first-in-human Phase Ⅰa study

Gang An, Yafei Wang, Hui Guo, Wanhong Zhao, Xiaobing Huang, Zhongjun Xia, Jian Chen, Xianlin Duan, Zeyu Yang, Xiaoyan Kang, Lugui Qiu

Blood (2025) 146 (Supplement 1): 5831.

https://doi.org/10.1182/blood-2025-5831

Published: 2025

Journal Articles

A first-in-human, phase I/II, open-label, multicenter, dose escalation and expansion study of lbl-034, a conditionally activated bispecific antibody targeting GPRC5D and CD3 with a 2:1 format, in patients with relapsed/refractory multiple myeloma

Blood (2025) 146 (Supplement 1): 91.

https://doi.org/10.1182/blood-2025-91

Published: 2025

Journal Articles

Efficacy and safety of azacitidine, venetoclax combined with gha priming regimen in the treatment of adult refractory and relapsed acute myeloid leukemia: A prospective single-arm multicenter study

Shan Meng, Xiaoping Liu, Li An, Xiaoya Shen, Huanhuan Tian, Hui Geng, Yan Li, Guoqiang Huang, Shuli Guo, Wanhong Zhao

Blood (2025) 146 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2025-1665

Published: 2025

Journal Articles

Comparison of Nutritional and Immunological Scoring Systems Predicting Prognosis before Anti-B Cell Maturation Antigen Chimeric Antigen Receptor-T Therapy in Multiple Myeloma, a Retrospective Study Based on Legend-2

Xuezhu Xu, Rui Liu, Ruoyu Yang, Wanhong Zhao, Baiyan Wang, Fangxia Wang, Aili He

Blood (2024) 144 (Supplement 1): 2411.1.

https://doi.org/10.1182/blood-2024-208950

Published: 2024

Journal Articles

Recombinant Human Thrombopoietin Combined with Thrombopoietin Receptor Agonists Can Facilitate the Recovery of Platelet after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Xuezhu Xu, Rui Liu, Ruoyu Yang, Aili He, Wanhong Zhao, Fangxia Wang

Blood (2024) 144 (Supplement 1): 5459.

https://doi.org/10.1182/blood-2024-209034

Published: 2024

Journal Articles

Single-Center Experience of Venetoclax Combined with Azacitidine in Young Patients with Newly Diagnosed Acute Myeloid Leukemia

Xuezhu Xu, Rui Liu, Ruoyu Yang, Fangxia Wang, Wanhong Zhao, Aili He

Blood (2024) 144 (Supplement 1): 7942.

https://doi.org/10.1182/blood-2024-209174

Published: 2024

Journal Articles

Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up

Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, Weijun Fu, Jianda Hu, Lijuan Chen, Yiwen Zhang, Dan Yao, Hui Li, Jordan M Schecter, Fan Yang, Huabin Sun, Sen Hong Zhuang, Da Xu, Tracy Luo, Xiaohu Fan, Ting Niu, Jie Jin, Sai-Juan Chen

Blood (2022) 140 (Supplement 1): 7542–7544.

https://doi.org/10.1182/blood-2022-159185

Published: 2022

Journal Articles

Identification of ST3GAL6-AS1 Interactive Protein in Multiple Myeloma

Ying Shen, MD, Fangmei Li, PhD, Dong Wu, MD, Yue Peng, Wanhong Zhao, MD, Yun Yang, MD, Jianli Wang, MD, Ju Bai, PhD, Yan Xu, Aili He

Blood (2019) 134 (Supplement_1): 4365.

https://doi.org/10.1182/blood-2019-125210

Published: 2019

Journal Articles

Using Circ-ANAPC7 As a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

Ying Shen, MD, Yachun Jia, Ru Zhang, MD, Hongli Chen, Yuandong Feng, MD, Fang-Xia Wang, MD PhD, Wanhong Zhao, MD, Jianli Wang, MD, Aili He, Yun Yang, MD, Yan Xu

Blood (2019) 134 (Supplement_1): 5179.

https://doi.org/10.1182/blood-2019-128179

Published: 2019

Journal Articles

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Asaka Kondo, Taishi Yamashita, Hideto Tamura, Wanhong Zhao, Takashi Tsuji, Masumi Shimizu, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata

Blood (2010) 116 (7): 1124–1131.

https://doi.org/10.1182/blood-2009-12-255125

Published: 2010

Includes: Supplemental data

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Azacitidine monotherapy versus combination regimens as post-allogeneic transplantation maintenance in high-risk myeloid malignancies: A retrospective cohort Study

QLS4131, a next-generation GPRC5D×BCMA×CD3 trispecific T-cell engager, in patients with relapsed/refractory multiple myeloma (RRMM): Initial results of a first-in-human Phase Ⅰa study

A first-in-human, phase I/II, open-label, multicenter, dose escalation and expansion study of lbl-034, a conditionally activated bispecific antibody targeting GPRC5D and CD3 with a 2:1 format, in patients with relapsed/refractory multiple myeloma

Efficacy and safety of azacitidine, venetoclax combined with gha priming regimen in the treatment of adult refractory and relapsed acute myeloid leukemia: A prospective single-arm multicenter study

Comparison of Nutritional and Immunological Scoring Systems Predicting Prognosis before Anti-B Cell Maturation Antigen Chimeric Antigen Receptor-T Therapy in Multiple Myeloma, a Retrospective Study Based on Legend-2

Recombinant Human Thrombopoietin Combined with Thrombopoietin Receptor Agonists Can Facilitate the Recovery of Platelet after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Single-Center Experience of Venetoclax Combined with Azacitidine in Young Patients with Newly Diagnosed Acute Myeloid Leukemia

Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up

Identification of ST3GAL6-AS1 Interactive Protein in Multiple Myeloma

Using Circ-ANAPC7 As a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only